Clinical Trial Update: Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating efficacy and safety to delay renal failure in children with Alport syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alport Syndrome
• Renal Insufficiency Chronic

Snippet

Sponsor: Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | Conditions: Renal Insufficiency, Chronic | Phase 3 | Status: COMPLETED